- Home
- / Epigenomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Epigenomics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.6
2024-10-29
Market Capitalization
€560.1 K
2024-10-29
Revenue
€24 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5M | 1.1M | 843.0K | 6.2M | 485.0K | 339.0K | 24.0K | |
| Cost of goods sold | 440.0K | 253.0K | 145.0K | 136.0K | 120.0K | 57.0K | ||
| Gross profit | 1.8M | 1.2M | 847.0K | 6.5M | 513.0K | 693.0K | 7.0K | 31.0K |
| Gross profit margin, % | 129.2% | |||||||
| Operating expense total | 14.8M | 15.8M | 10.4M | 10.2M | 12.6M | 8.0M | 916.0K | 409.0K |
| Depreciation and amortization | 308.0K | 513.0K | 535.0K | 419.0K | 749.0K | 797.0K | 12.0K | |
| EBITDA | (13.0M) | (14.6M) | (9.6M) | (3.7M) | (12.1M) | (7.3M) | (849.0K) | (333.0K) |
| EBITDA margin, % | -1387.5% | |||||||
| EBIT | (13.3M) | (15.1M) | (10.1M) | (4.2M) | (12.9M) | (7.5M) | (861.0K) | (333.0K) |
| EBIT margin, % | -1387.5% | |||||||
| Interest income | 17.0K | 172.0K | 21.0K | 12.0K | 99.0K | 35.0K | 37.0K | 39.0K |
| Interest expense | 552.0K | 65.0K | 57.0K | 68.0K | 149.0K | |||
| Pre tax profit | (13.4M) | (14.6M) | (11.7M) | (2.4M) | (12.1M) | (4.5M) | (3.4M) | (314.0K) |
| Income tax expense | (738.0K) | 2.5M | 23.0K | 18.0K | (77.0K) | |||
| Net Income | (12.7M) | (17.0M) | (11.7M) | (2.4M) | (12.0M) | (4.5M) | (3.4M) | (314.0K) |